Compare Neuromonics vs Portaero
Customers evaluate the quality of Neuromonics's products using the following success metrics.
Overview
Neuromonics is based in United States
Neuromonics is an Australian company that has developed an FDA approved device for treatment of tinnitus over a six month process with 2 hours of use per day.
Portaero is based in United States
Portaero, in stealth mode, is a medical devices firm, developing a device for the treatment of COPD (Chronic obstructive pulmonary disease).
Demo Video
Leadership
Eula Adams (Chief Executive Officer)
Dave Plough (Chief Executive Officer)
Investors
Innovation Capital Limited and GBS Venture Partners
Versant Ventures, Aberdare Ventures
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Neuromonics has not claimed their profile.
Work for Neuromonics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Neuromonics?
Claim your profile now.
Information not available because Portaero has not claimed their profile.
Work for Portaero? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Portaero?
Claim your profile now.